{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:01:39Z","timestamp":1791842499983,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","award":["48111668950485"],"award-info":[{"award-number":["48111668950485"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immunity with SARS-CoV-2 infection during the acute phase is not sufficiently well understood to differentiate mild from severe cases and identify prognostic markers. We evaluated the immune response profile using a total of 71 biomarkers in sera from patients with SARS-CoV-2 infection, confirmed by RT-PCR and controls. We correlated biological marker levels with negative control (C) asymptomatic (A), nonhospitalized (mild cases-M), and hospitalized (severe cases-S) groups. Among angiogenesis markers, we identified biomarkers that were more frequently elevated in severe cases when compared to the other groups (C, A, and M). Among cardiovascular diseases, there were biomarkers with differences between the groups, with D-dimer, GDF-15, and sICAM-1 higher in the S group. The levels of the biomarkers Myoglobin and P-Selectin were lower among patients in group M compared to those in groups S and A. Important differences in cytokines and chemokines according to the clinical course were identified. Severe cases presented altered levels when compared to group C. This study helps to characterize biological markers related to angiogenesis, growth factors, heart disease, and cytokine\/chemokine production in individuals infected with SARS-CoV-2, offering prognostic signatures and a basis for understanding the biological factors in disease severity.<\/jats:p>","DOI":"10.1038\/s41598-022-20062-5","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T09:07:44Z","timestamp":1664183264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Serum biomarkers associated with SARS-CoV-2 severity"],"prefix":"10.1038","volume":"12","author":[{"given":"Fabiani","family":"de Morais Batista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio Moreira","family":"Puga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Vieira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Cesar Pereira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Oliveira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Bento","family":"Tatara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Henrique","family":"Tsuha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida","family":"dos Santos Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crhistinne Cavalheiro Maymone","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f4mulo","family":"Pessoa e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1lia Tavares","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Pinheiro","family":"de Barros Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"da Silva Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia Edilaine Lopes","family":"Consolaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Juliano","family":"Negr\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idalina Cristina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano Pamplona","family":"de Goes Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Soares","family":"Trinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme S.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moacyr Jesus Barreto","family":"de Melo R\u00eago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary J.","family":"Boyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Machado","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Croda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"20062_CR1","unstructured":"BRASIL. Minist\u00e9rio da sa\u00fade. Diretrizes para diagn\u00f3stico e tratamento da Covid-19. Bras\u00edlia-DF (2020)."},{"key":"20062_CR2","doi-asserted-by":"publisher","first-page":"607647","DOI":"10.3389\/fped.2020.607647","volume":"8","author":"M Samprathi","year":"2020","unstructured":"Samprathi, M. & Jayashree, M. Biomarkers in COVID-19: An up-to-date review. Front. Pediatr. 8, 607647 (2020).","journal-title":"Front. Pediatr."},{"key":"20062_CR3","doi-asserted-by":"publisher","first-page":"102833","DOI":"10.1016\/j.ebiom.2020.102833","volume":"57","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine 57, 102833 (2020).","journal-title":"EBioMedicine"},{"key":"20062_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., R\u00e9nia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: Immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 1\u201312. https:\/\/doi.org\/10.1038\/s41577-020-0311-8 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"20062_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","volume":"146","author":"I Quinti","year":"2020","unstructured":"Quinti, I. et al. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J. Allergy Clin. Immunol. 146, 211-213.e4 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"20062_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41598-022-05186-y","volume":"12","author":"V D\u2019Onofrio","year":"2022","unstructured":"D\u2019Onofrio, V. et al. Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy. Sci. Rep. 12, 1360 (2022).","journal-title":"Sci. Rep."},{"key":"20062_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","volume":"142","author":"PP Liu","year":"2020","unstructured":"Liu, P. P., Blet, A., Smyth, D. & Li, H. The science underlying COVID-19: Implications for the cardiovascular system. Circulation 142, 68\u201378 (2020).","journal-title":"Circulation"},{"key":"20062_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 18, 1094\u20131099 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"20062_CR9","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/jth.14842","volume":"18","author":"A Porfidia","year":"2020","unstructured":"Porfidia, A. & Pola, R. Venous thromboembolism in COVID-19 patients. J. Thromb. Haemost. 18, 1516\u20131517 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"20062_CR10","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","volume":"383","author":"RT Gandhi","year":"2020","unstructured":"Gandhi, R. T., Lynch, J. B. & Del Rio, C. Mild or moderate Covid-19. N. Engl. J. Med. 383, 1757\u20131766 (2020).","journal-title":"N. Engl. J. Med."},{"key":"20062_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","volume":"46","author":"W Alhazzani","year":"2020","unstructured":"Alhazzani, W. et al. Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 46, 854\u2013887 (2020).","journal-title":"Intensive Care Med."},{"key":"20062_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.mayocp.2020.04.006","volume":"95","author":"J Xie","year":"2020","unstructured":"Xie, J. et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin. Proc. 95, 1138\u20131147 (2020).","journal-title":"Mayo Clin. Proc."},{"key":"20062_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5937\/jomb0-27554","volume":"39","author":"M Ahnach","year":"2020","unstructured":"Ahnach, M., Zbiri, S., Nejjari, S., Ousti, F. & Elkettani, C. C-reactive protein as an early predictor of COVID-19 severity. J. Med. Biochem. 39, 500\u2013507 (2020).","journal-title":"J. Med. Biochem."},{"key":"20062_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395, 507\u2013513 (2020).","journal-title":"Lancet"},{"key":"20062_CR15","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Internal Med. 180, 934\u2013943 (2020).","journal-title":"China JAMA Internal Med."},{"key":"20062_CR16","doi-asserted-by":"publisher","first-page":"e12421","DOI":"10.15252\/emmm.202012421","volume":"12","author":"T Liu","year":"2020","unstructured":"Liu, T. et al. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol. Med. 12, e12421 (2020).","journal-title":"EMBO Mol. Med."},{"key":"20062_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3389\/fimmu.2019.00861","volume":"10","author":"SK Panda","year":"2019","unstructured":"Panda, S. K. & Colonna, M. Innate lymphoid cells in mucosal immunity. Front. Immunol. 10, 861 (2019).","journal-title":"Front. Immunol."},{"key":"20062_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"20062_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"20062_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijid.2021.09.021","volume":"112","author":"V Vacharathit","year":"2021","unstructured":"Vacharathit, V. et al. SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile. Int. J. Infect. Dis. 112, 227\u2013234 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"20062_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbrc.2016.07.097","volume":"478","author":"JAQA Faria","year":"2016","unstructured":"Faria, J. A. Q. A., de Andrade, C., Goes, A. M., Rodrigues, M. A. & Gomes, D. A. Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation. Biochem. Biophys. Res. Commun. 478, 39\u201345 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20062_CR22","first-page":"F179","volume":"1333","author":"G Raab","year":"1997","unstructured":"Raab, G. & Klagsbrun, M. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta 1333, F179-199 (1997).","journal-title":"Biochim. Biophys. Acta"},{"key":"20062_CR23","doi-asserted-by":"publisher","unstructured":"Singh, B., Carpenter, G. & Coffey, R. J. EGF receptor ligands: Recent advances. Preprint at https:\/\/doi.org\/10.12688\/f1000research.9025.1 (2016).","DOI":"10.12688\/f1000research.9025.1"},{"key":"20062_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet 395, 497\u2013506 (2020).","journal-title":"China. Lancet"},{"key":"20062_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1182\/blood.V80.5.1289.1289","volume":"80","author":"D Benjamin","year":"1992","unstructured":"Benjamin, D., Knobloch, T. J. & Dayton, M. A. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt\u2019s lymphoma constitutively secrete large quantities of interleukin-10. Blood 80, 1289\u20131298 (1992).","journal-title":"Blood"},{"key":"20062_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1084\/jem.173.2.507","volume":"173","author":"L Thompson-Snipes","year":"1991","unstructured":"Thompson-Snipes, L. et al. Interleukin 10: A novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173, 507\u2013510 (1991).","journal-title":"J. Exp. Med."},{"key":"20062_CR27","doi-asserted-by":"publisher","first-page":"103378","DOI":"10.1016\/j.ebiom.2021.103378","volume":"67","author":"S de Bruin","year":"2021","unstructured":"de Bruin, S. et al. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine 67, 103378 (2021).","journal-title":"EBioMedicine"},{"key":"20062_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000512007","volume":"88","author":"GD Wool","year":"2021","unstructured":"Wool, G. D. & Miller, J. L. The impact of COVID-19 disease on platelets and coagulation. Pathobiology 88, 15\u201327 (2021).","journal-title":"Pathobiology"},{"key":"20062_CR29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin, C. et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan. China. Clin. Infect. Dis. 71, 762\u2013768 (2020).","journal-title":"China. Clin. Infect. Dis."},{"key":"20062_CR30","doi-asserted-by":"crossref","unstructured":"Ebihara, T. et al. Cytokine elevation in severe COVID-19 from longitudinal proteomics analysis: Comparison with sepsis. Front. Immunol. 12, (2022).","DOI":"10.3389\/fimmu.2021.798338"},{"key":"20062_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","volume":"51","author":"W Ershler","year":"2000","unstructured":"Ershler, W. & Keller, E. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 51, 245 (2000).","journal-title":"Annu. Rev. Med."},{"key":"20062_CR32","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s42003-022-03537-z","volume":"5","author":"DL Tartaro","year":"2022","unstructured":"Tartaro, D. L. et al. Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia. Commun. Biol. 5, 590 (2022).","journal-title":"Commun. Biol."},{"key":"20062_CR33","doi-asserted-by":"crossref","unstructured":"Ling, L. et al. Longitudinal cytokine profile in patients with mild to critical COVID-19. Front. Immunol. 12, (2021).","DOI":"10.3389\/fimmu.2021.763292"},{"key":"20062_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40560-020-00466-z","volume":"8","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J. Intensive Care 8, 49 (2020).","journal-title":"J. Intensive Care"},{"key":"20062_CR35","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/jth.14859","volume":"18","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J. Thromb. Haemost. 18, 1324\u20131329 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"20062_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/v13030419","volume":"13","author":"F Qeadan","year":"2021","unstructured":"Qeadan, F. et al. Prognostic values of serum ferritin and D-dimer trajectory in patients with COVID-19. Viruses 13, 419 (2021).","journal-title":"Viruses"},{"key":"20062_CR37","doi-asserted-by":"publisher","first-page":"e0256744","DOI":"10.1371\/journal.pone.0256744","volume":"16","author":"A Poudel","year":"2021","unstructured":"Poudel, A. et al. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS ONE 16, e0256744 (2021).","journal-title":"PLoS ONE"},{"key":"20062_CR38","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.120.050360","volume":"142","author":"PL Myhre","year":"2020","unstructured":"Myhre, P. L. et al. Growth differentiation factor 15 provides prognostic information superior to established cardiovascular and inflammatory biomarkers in unselected patients hospitalized with COVID-19. Circulation 142, 2128\u20132137 (2020).","journal-title":"Circulation"},{"key":"20062_CR39","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.4049\/jimmunol.162.5.2990","volume":"162","author":"C Lawson","year":"1999","unstructured":"Lawson, C., Ainsworth, M., Yacoub, M. & Rose, M. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-\u03baB-independent mechanism. J. Immunol. 162, 2990\u20132996 (1999).","journal-title":"J. Immunol."},{"key":"20062_CR40","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1021\/acschemneuro.0c00294","volume":"11","author":"X-X Yin","year":"2020","unstructured":"Yin, X.-X., Zheng, X.-R., Peng, W., Wu, M.-L. & Mao, X.-Y. Vascular endothelial growth factor (VEGF) as a vital target for brain inflammation during the COVID-19 outbreak. ACS Chem. Neurosci. 11, 1704\u20131705 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"20062_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1165\/ajrcmb.22.6.3779","volume":"22","author":"RJ Kaner","year":"2000","unstructured":"Kaner, R. J. et al. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am. J. Respir. Cell Mol. Biol. 22, 657\u2013664 (2000).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"20062_CR42","doi-asserted-by":"publisher","first-page":"15809","DOI":"10.1073\/pnas.95.26.15809","volume":"95","author":"HH Marti","year":"1998","unstructured":"Marti, H. H. & Risau, W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. USA 95, 15809\u201315814 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"20062_CR43","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3390\/jcm10092017","volume":"10","author":"\u00c1 Tamayo-Velasco","year":"2021","unstructured":"Tamayo-Velasco, \u00c1. et al. HGF, IL-1\u03b1, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients. J. Clin. Med. 10, 2017 (2021).","journal-title":"J. Clin. Med."},{"key":"20062_CR44","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1038\/s41467-021-25191-5","volume":"12","author":"M Perreau","year":"2021","unstructured":"Perreau, M. et al. The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients. Nat. Commun. 12, 4888 (2021).","journal-title":"Nat. Commun."},{"key":"20062_CR45","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.3389\/fimmu.2021.681516","volume":"12","author":"J Guo","year":"2021","unstructured":"Guo, J. et al. Cytokine Signature Associated With Disease Severity in COVID-19. Front. Immunol. 12, 3276 (2021).","journal-title":"Front. Immunol."},{"key":"20062_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1359-6101(00)00013-7","volume":"11","author":"R Iwamoto","year":"2000","unstructured":"Iwamoto, R. & Mekada, E. Heparin-binding EGF-like growth factor: A juxtacrine growth factor. Cytokine Growth Factor Rev. 11, 335\u2013344 (2000).","journal-title":"Cytokine Growth Factor Rev."},{"key":"20062_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1210\/jc.2004-0476","volume":"90","author":"K Chobotova","year":"2005","unstructured":"Chobotova, K. et al. Heparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cells. J. Clin. Endocrinol. Metab. 90, 913\u2013919 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"20062_CR48","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1210\/jcem.87.3.8350","volume":"87","author":"SL Young","year":"2002","unstructured":"Young, S. L. et al. In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor. J. Clin. Endocrinol. Metab. 87, 1368\u20131375 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"20062_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nm0102-35","volume":"8","author":"M Asakura","year":"2002","unstructured":"Asakura, M. et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy. Nat. Med. 8, 35\u201340 (2002).","journal-title":"Nat. Med."},{"key":"20062_CR50","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cellsig.2011.01.006","volume":"23","author":"K-S Lee","year":"2011","unstructured":"Lee, K.-S., Park, J.-H., Lim, H.-J. & Park, H.-Y. HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway. Cell Signal 23, 1100\u20131109 (2011).","journal-title":"Cell Signal"},{"key":"20062_CR51","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1172\/JCI117669","volume":"95","author":"J Miyagawa","year":"1995","unstructured":"Miyagawa, J. et al. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest. 95, 404\u2013411 (1995).","journal-title":"J. Clin. Invest."},{"key":"20062_CR52","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/08977190903443030","volume":"28","author":"E S\u00e1nchez-Vizca\u00edno","year":"2010","unstructured":"S\u00e1nchez-Vizca\u00edno, E. et al. Heparin-binding EGF-like growth factor in human serum. Association with high blood cholesterol and heart hypertrophy. Growth Factors 28, 98\u2013103 (2010).","journal-title":"Growth Factors"},{"key":"20062_CR53","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1536\/ihj.17-644","volume":"59","author":"S Tsuchida","year":"2018","unstructured":"Tsuchida, S. et al. Anti-HB-EGF antibody-mediated delivery of siRNA to atherosclerotic lesions in mice. Int. Heart J. 59, 1425\u20131431 (2018).","journal-title":"Int. Heart J."},{"key":"20062_CR54","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1038\/onc.2016.465","volume":"36","author":"C-H Hsieh","year":"2017","unstructured":"Hsieh, C.-H. et al. A targetable HB-EGF\u2013CITED4 axis controls oncogenesis in lung cancer. Oncogene 36, 2946\u20132956 (2017).","journal-title":"Oncogene"},{"key":"20062_CR55","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3389\/fonc.2020.01019","volume":"10","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. HB-EGF Activates the EGFR\/HIF-1\u03b1 pathway to induce proliferation of arsenic-transformed cells and tumor growth. Front. Oncol. 10, 1019 (2020).","journal-title":"Front. Oncol."},{"key":"20062_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41374-018-0146-0","volume":"99","author":"MS Eapen","year":"2019","unstructured":"Eapen, M. S. et al. Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: Implications for disease pathogenesis and novel therapies. Lab Invest. 99, 150\u2013157 (2019).","journal-title":"Lab Invest."},{"key":"20062_CR57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12890-021-01726-w","volume":"21","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. HB-EGF-induced IL-8 secretion from airway epithelium leads to lung fibroblast proliferation and migration. BMC Pulm. Med. 21, 347 (2021).","journal-title":"BMC Pulm. Med."},{"key":"20062_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1440-1827.1996.tb03584.x","volume":"46","author":"LH Pan","year":"1996","unstructured":"Pan, L. H., Ohtani, H., Yamauchi, K. & Nagura, H. Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases: An immunohistochemical analysis. Pathol. Int. 46, 91\u201399 (1996).","journal-title":"Pathol. Int."},{"key":"20062_CR59","doi-asserted-by":"publisher","first-page":"20638","DOI":"10.1038\/s41598-021-98253-9","volume":"11","author":"Y Kimura","year":"2021","unstructured":"Kimura, Y. et al. Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach. Sci. Rep. 11, 20638 (2021).","journal-title":"Sci. Rep."},{"key":"20062_CR60","unstructured":"COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk & COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185, 916\u2013938.e58 (2022)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20062-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T14:32:28Z","timestamp":1676903548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20062-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20062"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20062-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15999"}}